Frontlight ResearchEarly access
WithdrawnNo phase
Cleanser for Acute Wounds
Key facts
- Who runs it
- Rochal Industries LLC
- Where
- Fort Sam Houston, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Jan 2024
- Ended
- 30 Apr 2025
- Type of study
- Interventional
- Treatments tested
- Antimicrobial Skin & Wound Cleanser (AWC)
- Antimicrobial Wound Gel (AWG)
- Record updated
- 4 May 2025
- Why it stopped
- That aim was forfeited due to enrollment challenges and lack of remaining funding to accomplish.
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Ages 18 to 89 years old
- Patients receiving care in the ED/trauma bay or admitted to Brooke Army Medical Center (BAMC) from the ED or trauma bay
- At least one wound area must measure equal to or greater than 2cm\^2 to include partial or full thickness tears
- Wound sustained less than 48-hours from time of enrollment
- The wound must be untreated/open beyond bedside stabilization such as irrigation and debridement (i.e., no stitches, steristrips, dermabond, OR washouts, etc)
- Capable of providing informed written consent by self or through Legally Authorized Representative (LAR)
- Ability to read/speak English (participant and/ or LAR)
Who cannot take part
- Patients not receiving care in the ED/trauma bay or admitted to BAMC through the ED or trauma bay
- Have received more than one dose of antibiotics prior to enrollment or during the study duration
- Patients receiving (within 30 days of enrollment) or scheduled to receive a medication or treatment which is known to negatively affect wound healing such as systemic steroids (i.e. continuous prednisone), immunosuppressive therapy, chemotherapy, autoimmune disease therapy, cytostatic therapy, vascular surgery, angioplasty, or thrombolysis
- Participation in another investigational device, drug, or biological trial that may interfere with results within 30 days of screening
- Suspected or confirmed signs/symptoms of active wound infection or gangrene
- Ages less than 18 or greater than 89 years old
- Wound area less than 2 cm2
- Wound sustained greater than 48-hours from the time of enrollment
- Wounds that have been closed/repaired at the time of screening (i.e. stitches, steristrips, dermabond, washouts in the OR, etc.) or anytime during the study duration
- Not capable of providing informed written consent by self or through LAR
- Non-English reading and speaking (participant and/or LAR)
- Patients with osteomyelitis
- Wounds with exposed tendons, ligaments, or bone
- Patients undergoing active renal dialysis
- Pregnant, breastfeeding, or women of childbearing potential who do not agree to use an effective form of contraception during their participation in the study
- Anyone deemed by the PI to be unlikely to comply with all study procedures
Where in United States
- Brooke Army Medical CenterFort Sam Houston, United States
About the trial
What the trial wants to find out
The proposed study will be a prospective trial of management of acute traumatic wounds (less than 24 hours from injury and without previous intervention aside from a dressing for coverage). The study design involves a prospective single arm, 35 subject study that analyzes the effect of the subsequent application of a novel wound cleanser and wound gel on subjects' acute traumatic wounds and the respective microbial loads over a 28 day study duration.
The group in the trial
- TreatmentTreatment being tested
Antimicrobial Skin \& Wound Cleanser and Antimicrobial Wound gel will be subsequently administered to the wound during the 28 day study duration.
Treatment: Antimicrobial Skin & Wound Cleanser (AWC) and Antimicrobial Wound Gel (AWG)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- BIAKOS Antimicrobial Wound Cleanser and BIAKOS Antimicrobial Wound Gel: Providing Biofilm Prevention and Treatment Through Continuum of Care
- Record updated
- 4 May 2025